Simultaneous Inhibition of BCR-ABL1 Tyrosine Kinase and PAK1/2 Serine/Threonine Kinase Exerts Synergistic Effect against Chronic Myeloid Leukemia Cells
Sylwia Flis(Narodowy Instytut Leków), Tomasz Skórski(Temple University)
Cited by 21
Related Papers
BCR/ABL and Other Kinases from Chronic Myeloproliferative Disorders Stimulate Single-Strand Annealing, an Unfaithful DNA Double-Strand Break Repair
|Cancer Research|2008|95
Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms
|Blood|2017|77
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells
|Journal of Clinical Investigation|2017|75